Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings
18 mai 2022 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 18, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
Predictive Oncology Announces $7.2 Million Registered Direct Offerings
16 mai 2022 08h55 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
Predictive Oncology Reports First Quarter Financial Results
12 mai 2022 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- The financial results from the first quarter we believe depicts a solid potential for growth in the upcoming period, in accordance with the report by...
Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology
26 avr. 2022 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that Theresa Ferguson has been named Senior Director of Marketing. As Predictive Oncology’s senior...
Predictive Oncology Reports Year End 2021 Financial Results and Provides Business Update
31 mars 2022 17h25 HE
|
Predictive Oncology Inc.
EAGAN, Minn., March 31, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology validates Discovery 21 proof-of-concept campaign
24 mars 2022 08h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, March 24, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) achieved a key milestone toward monetizing its unique approach to leverage artificial intelligence (AI) in oncology...
Predictive Oncology set to market AI drug discovery platform
27 janv. 2022 07h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is set to be a first mover in the artificial intelligence (AI) powered drug discovery market that POAI expects...
POAI Reports Strong Results From Its AI Cancer Drug Evaluation
13 janv. 2022 08h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) reported the preliminary results of its Discovery 2021 program today, announcing that its Helomics subsidiary’s...
Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021
27 déc. 2021 17h10 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology – Year-end Shareholder Update!
21 déc. 2021 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, is...